HypertensionNCT05876624
The Connection Between Personality, Burnout, and Hypertension in Nigerian Bank Employees
An observational study of Hypertension, run by Renaissance University Ugbawka, Enugu at 1 site in Nigeria.
Trial summary
This is a longitudinal study which we plan to examine the link between personality traits, burnout, and hypertension in bank employees in South-eastern Nigeria Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Hypertension
- What is being tested?
- Blood Pressure measurement
- How many people
- 600 participants
- Where
- 1 siteNigeria
- Study dates
- 22 May 2023to 10 Jul 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Child, Adult, Older adult
Study population: all Staff of commercial banks in Nigeria
Who may be able to join
- Any staff of the Bank
Who cannot join
- Non Staff
Trial locations and contacts
1 site in 1 country.
About this study
Official title: High Stakes, High Pressure: The Connection Between Personality, Burnout, and Hypertension in Nigerian Bank Employees
This is a longitudinal study which we plan to examine the link between personality traits, burnout, and hypertension in bank employees in South-eastern Nigeria
Read the detailed description
This proposed longitudinal study aims to examine the relationship between personality traits, burnout, and hypertension in bank employees in South-eastern Nigeria, where hypertension is a significant public health issue. The study will involve bankers as participants, who will be asked to complete self-report questionnaires and measure their blood pressure over four weeks. The research seeks to determine if personality differences and burnout levels contribute to hypertension risk in this population. By understanding the role of psychosocial factors in hypertension risk, the study hopes to provide recommendations for workplace adjustments that could improve employee well-being and reduce hypertension risk among Nigerian bank employees.
- Conditions
- Hypertension
- Being tested
- Blood Pressure measurement
- Medical subject headings
- Hypertension
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Blood Pressure measurementOther
Also called Blood Pressure
Blood Pressure measurement
What is being measured
The primary outcome is the main question the study is designed to answer.
Blood Pressure
Blood Pressure measurement
Measured: 20 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 May 2023
- Study start22 May 2023 (estimated)
- Primary completion19 Jun 2023 (estimated)
- Study completion10 Jul 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HypertensionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 600 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Renaissance University Ugbawka, Enugu
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Lawrence Ugwu, Renaissance University Ugbawka, Enugu
- Investigators
- Lawrence E Ugwu, Principal investigator, Renaissance University Ugbawka Enugu Nigeria
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05876624
- Sponsor's protocol ID
- RenaissanceU
- Status last verified
- May 2023
- First submitted
- 17 May 2023
- Last updated
- 25 May 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: We No plan of sharing the data.
Study at a glance
From the registry record, last updated by the sponsor on 25 May 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- High Stakes, High Pressure: The Connection Between Personality, Burnout, and Hypertension in Nigerian Bank Employees
- ClinicalTrials.gov ID
- NCT05876624
- Acronym / sponsor ID
- RenaissanceU
- Conditions
- Hypertension
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 600 participants (estimated)
- Lead sponsor
- Renaissance University Ugbawka, EnuguUniversity, hospital or other
- Study start
- 22 May 2023 (estimated)
- Primary completion
- 19 Jun 2023 (estimated)
- Study completion
- 10 Jul 2023 (estimated)
- First posted
- 25 May 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a longitudinal study which we plan to examine the link between personality traits, burnout, and hypertension in bank employees in South-eastern Nigeria
Detailed description
This proposed longitudinal study aims to examine the relationship between personality traits, burnout, and hypertension in bank employees in South-eastern Nigeria, where hypertension is a significant public health issue. The study will involve bankers as participants, who will be asked to complete self-report questionnaires and measure their blood pressure over four weeks. The research seeks to determine if personality differences and burnout levels contribute to hypertension risk in this population. By understanding the role of psychosocial factors in hypertension risk, the study hopes to provide recommendations for workplace adjustments that could improve employee well-being and reduce hypertension risk among Nigerian bank employees.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Sex
- All
- Age groups
- Child, Adult, Older adult
- Study population
- all Staff of commercial banks in Nigeria
Key inclusion criteria (1 listed)
- Any staff of the Bank
Key exclusion criteria (1 listed)
- Non Staff
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Blood Pressure measurementAlso: Blood PressureBlood Pressure measurement | Other | – |
Primary outcome
Blood Pressure
Time frame: 20 minutes
Blood Pressure measurement
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 May 2023.
- Individual participant dataSharing planned: No. We No plan of sharing the data.
Related trials for Hypertension
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Not yet recruitingPhase 2/3
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Enrolling by invitation
Testing Implementation Strategies to Support Clinic Fidelity to an Outpatient Hypertension Bundle
Pregnancy Related, Hypertension
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Lawrence E Ugwu principal investigator
Renaissance University Ugbawka Enugu Nigeria
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hypertension, run by Renaissance University Ugbawka, Enugu at 1 site in Nigeria.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 25 May 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Nigeria. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Blood Pressure (time frame: 20 minutes). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 May 2023.